137 related articles for article (PubMed ID: 35131617)
21. Fire ant venom alkaloid, isosolenopsin A, a potent and selective inhibitor of neuronal nitric oxide synthase.
Yi GB; McClendon D; Desaiah D; Goddard J; Lister A; Moffitt J; Meer RK; deShazo R; Lee KS; Rockhold RW
Int J Toxicol; 2003; 22(2):81-6. PubMed ID: 12745988
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and pharmacological evaluations of N-(substituted benzoylamino)-5-carbethoxymethyl-1,2,3,6-tetrahydropyridines as potential antiinflammatory agents.
Yoon K; Wilson T; Williams S; Redda K
Drugs Exp Clin Res; 2000; 26(3):73-82. PubMed ID: 10941599
[TBL] [Abstract][Full Text] [Related]
23. Involvement and dual effects of nitric oxide in septic shock.
Wolkow PP
Inflamm Res; 1998 Apr; 47(4):152-66. PubMed ID: 9628258
[TBL] [Abstract][Full Text] [Related]
24. Aromatic reduced amide bond peptidomimetics as selective inhibitors of neuronal nitric oxide synthase.
Hah JM; Martásek P; Roman LJ; Silverman RB
J Med Chem; 2003 Apr; 46(9):1661-9. PubMed ID: 12699384
[TBL] [Abstract][Full Text] [Related]
25. Nitric oxide synthase modulates CFA-induced thermal hyperalgesia through cytokine regulation in mice.
Chen Y; Boettger MK; Reif A; Schmitt A; Uçeyler N; Sommer C
Mol Pain; 2010 Mar; 6():13. PubMed ID: 20193086
[TBL] [Abstract][Full Text] [Related]
26. Inducible nitric oxide synthase--time for reappraisal.
Lirk P; Hoffmann G; Rieder J
Curr Drug Targets Inflamm Allergy; 2002 Mar; 1(1):89-108. PubMed ID: 14561209
[TBL] [Abstract][Full Text] [Related]
27. Spontaneous rearrangement of aminoalkylisothioureas into mercaptoalkylguanidines, a novel class of nitric oxide synthase inhibitors with selectivity towards the inducible isoform.
Southan GJ; Zingarelli B; O'Connor M; Salzman AL; Szabó C
Br J Pharmacol; 1996 Feb; 117(4):619-32. PubMed ID: 8646406
[TBL] [Abstract][Full Text] [Related]
28. Discovery of N-{3-[(ethanimidoylamino)methyl]benzyl}-l-prolinamide dihydrochloride: A new potent and selective inhibitor of the inducible nitric oxide synthase as a promising agent for the therapy of malignant glioma.
Maccallini C; Di Matteo M; Gallorini M; Montagnani M; Graziani V; Ammazzalorso A; Amoia P; De Filippis B; Di Silvestre S; Fantacuzzi M; Giampietro L; Potenza MA; Re N; Pandolfi A; Cataldi A; Amoroso R
Eur J Med Chem; 2018 May; 152():53-64. PubMed ID: 29689474
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological evaluation of 5-nitropyrimidine-2,4-dione analogues as inhibitors of nitric oxide and iNOS activity.
Ma L; He L; Lei L; Liang X; Lei K; Zhang R; Yang Z; Chen L
Chem Biol Drug Des; 2015 Mar; 85(3):296-9. PubMed ID: 24985766
[TBL] [Abstract][Full Text] [Related]
30. Comparison of effects of nitric oxide synthase (NOS) inhibitors on plasma nitrite/nitrate levels and tissue NOS activity in septic organs.
Hayashi Y; Abe M; Murai A; Shimizu N; Okamoto I; Katsuragi T; Tanaka K
Microbiol Immunol; 2005; 49(2):139-47. PubMed ID: 15722599
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis and characterization of a novel class of coumarin-based inhibitors of inducible nitric oxide synthase.
Jackson SA; Sahni S; Lee L; Luo Y; Nieduzak TR; Liang G; Chiang Y; Collar N; Fink D; He W; Laoui A; Merrill J; Boffey R; Crackett P; Rees B; Wong M; Guilloteau JP; Mathieu M; Rebello SS
Bioorg Med Chem; 2005 Apr; 13(8):2723-39. PubMed ID: 15781384
[TBL] [Abstract][Full Text] [Related]
32. iNOS as a metabolic enzyme under stress conditions.
Anavi S; Tirosh O
Free Radic Biol Med; 2020 Jan; 146():16-35. PubMed ID: 31672462
[TBL] [Abstract][Full Text] [Related]
33. Down-regulation of neuronal nitric oxide synthase by nitric oxide after oxygen-glucose deprivation in rat forebrain slices.
De Alba J; Cárdenas A; Moro MA; Leza JC; Lorenzo P; Boscá L; Lizasoain I
J Neurochem; 1999 Jan; 72(1):248-54. PubMed ID: 9886076
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and evaluation of trans 3,4-cyclopropyl L-arginine analogues as isoform selective inhibitors of nitric oxide synthase.
Fishlock D; Perdicakis B; Montgomery HJ; Guillemette JG; Jervis E; Lajoie GA
Bioorg Med Chem; 2003 Mar; 11(6):869-73. PubMed ID: 12614872
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and evaluation of new sulfur-containing L-arginine-derived inhibitors of nitric oxide synthase.
Ichimori K; Stuehr DJ; Atkinson RN; King SB
J Med Chem; 1999 May; 42(10):1842-8. PubMed ID: 10346937
[TBL] [Abstract][Full Text] [Related]
36. Regulation of cyclooxygenase activity and progesterone production in the rat corpus luteum by inducible nitric oxide synthase.
Hurwitz A; Finci-Yeheskel Z; Milwidsky A; Mayer M
Reproduction; 2002 May; 123(5):663-9. PubMed ID: 12006094
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of nitric oxide production from lipopolysaccharide-treated RAW 264.7 cells by synthetic flavones: structure-activity relationship and action mechanism.
Kim SJ; Park H; Kim HP
Arch Pharm Res; 2004 Sep; 27(9):937-43. PubMed ID: 15473664
[TBL] [Abstract][Full Text] [Related]
38. Phenylpyrrole derivatives as neural and inducible nitric oxide synthase (nNOS and iNOS) inhibitors.
López Cara LC; Camacho ME; Carrión MD; Tapias V; Gallo MA; Escames G; Acuña-Castroviejo D; Espinosa A; Entrena A
Eur J Med Chem; 2009 Jun; 44(6):2655-66. PubMed ID: 19117642
[TBL] [Abstract][Full Text] [Related]
39. Inducible nitric oxide synthase in the liver: regulation and function.
Taylor BS; Alarcon LH; Billiar TR
Biochemistry (Mosc); 1998 Jul; 63(7):766-81. PubMed ID: 9721329
[TBL] [Abstract][Full Text] [Related]
40. Novel substrates for nitric oxide synthases.
Xian M; Fujiwara N; Wen Z; Cai T; Kazuma S; Janczuk AJ; Tang X; Telyatnikov VV; Zhang Y; Chen X; Miyamoto Y; Taniguchi N; Wang PG
Bioorg Med Chem; 2002 Sep; 10(9):3049-55. PubMed ID: 12110328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
